[Ip-health] HHS Pharmaceutical Forum 11/20

Andrew S. Goldman andrew.goldman at keionline.org
Mon Nov 16 19:06:05 PST 2015


It has been difficult to find out details about the HHS Pharmaceutical
Forum that will happen on Friday, 11/20, but I wanted to share a few things
that I have learned.

The agenda is listed as follows:

Agenda

Time SlotAgenda Item

9:00 a.m. – 9:15 a.m.

Welcome & the Impact of Rising Pharmaceutical Costs

Presenters will discuss the complex problem of rising drug costs, the
impact on patients, businesses, taxpayers, and state and federal budgets,
and the challenge of balancing innovation with affordability.

9:15 a.m. – 10:15 a.m.

The Balance between Innovation & Smarter Spending

This session will examine the current and future drug classes that
contribute to rising health care costs, as well as the impact of innovative
and breakthrough therapies in the pipeline on patient care.

10:30 a.m. – 11:45 a.m.

Patient Access & the Affordability of Prescription Drugs

The panel will highlight significant challenges for patients and providers
in accessing drugs and discuss opportunities to increase access and
affordability, and to reward quality of care that drives increased value.

1:00 p.m. – 2:15 p.m.

Purchasing Strategies & Utilization Management Best Practices

Panelists will share approaches to innovative purchasing strategies,
identify best practices within these models, and how the innovations could
be implemented in Medicare and Medicaid.

2:30 p.m. – 3:45 p.m.

Value-Based & Outcomes-Based Pharmaceutical Purchasing Programs

Panelists will discuss value-based and outcomes-based purchasing strategies
with a focus on identifying successful elements of these models that can be
implemented broadly, and provide some implementation lessons learned from
market leaders.
--
The forum will be webcast live from this website:
http://www.hhs.gov/hhspharmaceuticalforum

The list of panelists has not been made public, but as of right now I have
heard that Mark McClelland, Doug Long (IMS Health), and Steve Miller
(Express Scripts) are among them.  More to be confirmed.

--
Andrew S. Goldman
Counsel, Policy and Legal Affairs
Knowledge Ecology International
andrew.goldman at keionline.org // www.twitter.com/ASG_KEI
tel.: +1.202.332.2670
www.keionline.org



More information about the Ip-health mailing list